Merck (MRK) Net Income - Minority (2009 - 2012)

Merck (MRK) posted quarterly Net Income - Minority of -$2.4 billion for Q4 2012, down 0.7% YoY from -$2.5 billion in Q1 2012, and down 0.7% sequentially from -$2.4 billion in Q4 2011.

Merck (MRK) Net Income - Minority (2009 - 2012) Analysis & Trends

Merck has disclosed Net Income - Minority across 4 years of filings, most recently posting -$2.4 billion for Q4 2012.

  • In Q4 2012, Net Income - Minority fell 0.7% year-over-year to -$2.4 billion; the TTM figure through Dec 2012 stood at -$2.4 billion (down 0.7% YoY), while the FY2012 annual figure was -$2.4 billion, down 0.7% from the prior year.
  • Net Income - Minority fell to -$2.4 billion in Q4 2012, from -$2.4 billion in the prior quarter.
  • Over the last five years, Net Income - Minority for MRK reached as high as -$2.4 billion in Q4 2011 and fell as low as -$2.5 billion in Q1 2010.
  • The 4-year median for Net Income - Minority is -$2.4 billion (2010), against an average of -$2.4 billion.
  • Annual changes were most pronounced in 2011 — Net Income - Minority advanced 0.41% — and 2012, when it retreated 0.7%.
  • A 4-year view of Net Income - Minority shows it stood at -$2.4 billion in 2009, then dropped by 0.08% to -$2.4 billion in 2010, then gained by 0.12% to -$2.4 billion in 2011, then declined by 0.7% to -$2.4 billion in 2012.
  • According to Business Quant data, Net Income - Minority over the past three periods registered -$2.4 billion, -$2.4 billion, and -$2.5 billion for Q4 2012, Q4 2011, and Q1 2011 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2012 -2.44 Bn
Dec 31, 2011 -2.43 Bn
Mar 31, 2011 -2.46 Bn
Dec 31, 2010 -2.43 Bn
Sep 30, 2010 -2.46 Bn
Jun 30, 2010 -2.43 Bn
Mar 31, 2010 -2.47 Bn
Dec 31, 2009 -2.43 Bn